FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
87 products match “Amgen, Inc” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Imlygictalimogene laherparepvec | Talimogene laherparepvec 1000000 [PFU]/mL | Injection, SuspensionIntralesional | Amgen Inc | 55513-078 |
| Imlygictalimogene laherparepvec | Talimogene laherparepvec 100000000 [PFU]/mL | Injection, SuspensionIntralesional | Amgen Inc | 55513-079 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 10 ug/.4mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-098 |
| Tezspiretezepelumab-ekko | Tezepelumab 210 mg/1.9mL | Injection, SolutionSubcutaneous | Amgen Inc | 55513-123 |
| Aranespdarbepoetin alfa | Darbepoetin alfa 300 ug/.6mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-111 |
| Tezspiretezepelumab-ekko | Tezepelumab 210 mg/1.9mL | Injection, SolutionSubcutaneous | Amgen Inc | 55513-112 |
| Kanjintitrastuzumab-anns | Trastuzumab 150 mg/7.15mL | Injection, Powder, Lyophilized, For solutionIntravenous | Amgen, Inc | 55513-141 |
|---|
| Epogenepoetin alfa | Epoetin 2000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-126 |
|---|
| Kanjintitrastuzumab-anns | Trastuzumab 420 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Amgen, Inc | 55513-132 |
|---|
| Otezlaapremilast | Apremilast 30 mg/1 | Tablet, Film coatedOral | Amgen, Inc | 55513-137 |
|---|
| Bkemveculizumab-aeeb | Eculizumab 300 mg/30mL | Injection, Solution, ConcentrateIntravenous | Amgen Inc | 55513-180 |
|---|
| Epogenepoetin alfa | Epoetin 10000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-144 |
|---|
| Epogenepoetin alfa | Epoetin 4000 [iU]/mL | SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-148 |
|---|
| Blincytoblinatumomab | — | Kit | Amgen, Inc | 55513-160 |
|---|
| Mvasibevacizumab-awwb | Bevacizumab 100 mg/4mL | Injection, SolutionIntravenous | Amgen, Inc | 55513-206 |
|---|
| Neulastapegfilgrastim | Pegfilgrastim 6 mg/.6mL | InjectionSubcutaneous | Amgen, Inc | 55513-190 |
|---|
| Neulastapegfilgrastim | — | Kit | Amgen, Inc | 55513-192 |
|---|
| Nplateromiplostim | Romiplostim 500 ug/mL | Injection, Powder, Lyophilized, For solutionSubcutaneous | Amgen, Inc | 55513-222 |
|---|
| Mvasibevacizumab-awwb | Bevacizumab 400 mg/16mL | Injection, SolutionIntravenous | Amgen, Inc | 55513-207 |
|---|
| Neupogenfilgrastim | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-209 |
|---|